These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 15118358

  • 1. Quetiapine treatment for behavioral and psychological symptoms in patients with senile dementia of Alzheimer type.
    Fujikawa T, Takahashi T, Kinoshita A, Kajiyama H, Kurata A, Yamashita H, Yamawaki S.
    Neuropsychobiology; 2004; 49(4):201-4. PubMed ID: 15118358
    [Abstract] [Full Text] [Related]

  • 2. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D, Barak Y, Mirecky I, Mazeh D.
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [Abstract] [Full Text] [Related]

  • 3. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.
    De Deyn PP, Wirshing WC.
    J Clin Psychiatry; 2001 Apr; 62 Suppl 21():19-22. PubMed ID: 11584983
    [Abstract] [Full Text] [Related]

  • 4. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML, Saina M, Trevisiol M, Cristante T, Aguglia E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):205-9. PubMed ID: 17020789
    [Abstract] [Full Text] [Related]

  • 5. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.
    Ito T, Meguro K, Akanuma K, Meguro M, Lee E, Kasuya M, Ishii H, Mori E.
    J Clin Neurosci; 2007 Sep 30; 14(9):850-5. PubMed ID: 17587584
    [Abstract] [Full Text] [Related]

  • 6. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A.
    Clin Neurol Neurosurg; 2005 Oct 30; 107(6):497-508. PubMed ID: 15922506
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of quetiapine in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML, Saina M, Aguglia E.
    Am J Alzheimers Dis Other Demen; 2005 Oct 30; 21(6):448-53. PubMed ID: 17267378
    [Abstract] [Full Text] [Related]

  • 8. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
    Rocca P, Marino F, Montemagni C, Perrone D, Bogetto F.
    Psychiatry Clin Neurosci; 2007 Dec 30; 61(6):622-9. PubMed ID: 18081622
    [Abstract] [Full Text] [Related]

  • 9. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H.
    Int J Geriatr Psychiatry; 2007 May 30; 22(5):475-84. PubMed ID: 17471598
    [Abstract] [Full Text] [Related]

  • 10. [Behavioral pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD): Spanish validation].
    Boada M, Tárraga L, Modinos G, Diego S, Reisberg B.
    Neurologia; 2006 May 30; 21(1):19-25. PubMed ID: 16525922
    [Abstract] [Full Text] [Related]

  • 11. Behavioral outcomes in clinical trials for Alzheimer disease.
    Ferris SH, Mackell JA.
    Alzheimer Dis Assoc Disord; 1997 May 30; 11 Suppl 4():S10-5. PubMed ID: 9339267
    [Abstract] [Full Text] [Related]

  • 12. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B, Vanelli M, Hyde J, Perez R, Ahokpossi C, Sribney W, Adkison L.
    Am J Geriatr Pharmacother; 2007 Sep 30; 5(3):209-17. PubMed ID: 17996660
    [Abstract] [Full Text] [Related]

  • 13. Comparison of topiramate and risperidone for the treatment of behavioral disturbances of patients with Alzheimer disease: a double-blind, randomized clinical trial.
    Mowla A, Pani A.
    J Clin Psychopharmacol; 2010 Feb 30; 30(1):40-3. PubMed ID: 20075646
    [Abstract] [Full Text] [Related]

  • 14. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.
    Monji A, Takita M, Samejima T, Takaishi T, Hashimoto K, Matsunaga H, Oda M, Sumida Y, Mizoguchi Y, Kato T, Horikawa H, Kanba S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar 17; 33(2):308-11. PubMed ID: 19138715
    [Abstract] [Full Text] [Related]

  • 15. Gender differences in clinical manifestations and outcomes among hospitalized patients with behavioral and psychological symptoms of dementia.
    Kitamura T, Kitamura M, Hino S, Tanaka N, Kurata K.
    J Clin Psychiatry; 2012 Dec 17; 73(12):1548-54. PubMed ID: 23290328
    [Abstract] [Full Text] [Related]

  • 16. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.
    Hayashi Y, Ishida Y, Inoue T, Udagawa M, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Sameshima T, Kawahara T, Goto I, Shudo K, Kurayama S, Nakamura J, Okahara K, Mitsuyama Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):541-5. PubMed ID: 20184936
    [Abstract] [Full Text] [Related]

  • 17. Neuropsychiatric symptoms of dementia: cross-sectional analysis from a prospective, longitudinal Belgian study.
    Engelborghs S, Maertens K, Nagels G, Vloeberghs E, Mariën P, Symons A, Ketels V, Estercam S, Somers N, De Deyn PP.
    Int J Geriatr Psychiatry; 2005 Nov 16; 20(11):1028-37. PubMed ID: 16250064
    [Abstract] [Full Text] [Related]

  • 18. Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin.
    Hamuro A, Saito S.
    Psychogeriatrics; 2010 Dec 16; 10(4):198-200. PubMed ID: 21159055
    [Abstract] [Full Text] [Related]

  • 19. Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia.
    Skjerve A, Holsten F, Aarsland D, Bjorvatn B, Nygaard HA, Johansen IM.
    Psychiatry Clin Neurosci; 2004 Aug 16; 58(4):343-7. PubMed ID: 15298644
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH, Greenspan AJ, Choi SK.
    Int J Geriatr Psychiatry; 2006 Jul 16; 21(7):654-60. PubMed ID: 16821257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.